Background: Using traditional patient-reported outcomes (PROs), such as paper-based questionnaires, is cumbersome in the era of web-based medical consultation and telemedicine. Electronic PROs may reduce the burden on patients if implemented widely. Considering promising reports of DryEyeRhythm, our in-house mHealth smartphone app for investigating dry eye disease (DED) and the electronic and paper-based Ocular Surface Disease Index (OSDI) should be evaluated and compared to determine their equivalency.
Objective: The purpose of this study is to assess the equivalence between smartphone app-based and paper-based questionnaires for DED.
Methods: This prospective, nonblinded, randomized crossover study enrolled 34 participants between April 2022 and June 2022 at a university hospital in Japan. The participants were allocated randomly into 2 groups in a 1:1 ratio. The paper-app group initially responded to the paper-based Japanese version of the OSDI (J-OSDI), followed by the app-based J-OSDI. The app-paper group responded to similar questionnaires but in reverse order. We performed an equivalence test based on minimal clinically important differences to assess the equivalence of the J-OSDI total scores between the 2 platforms (paper-based vs app-based). A 95% CI of the mean difference between the J-OSDI total scores within the ±7.0 range between the 2 platforms indicated equivalence. The internal consistency and agreement of the app-based J-OSDI were assessed with Cronbach α coefficients and intraclass correlation coefficient values.
Results: A total of 33 participants were included in this study. The total scores for the app- and paper-based J-OSDI indicated satisfactory equivalence per our study definition (mean difference 1.8, 95% CI -1.4 to 5.0). Moreover, the app-based J-OSDI total score demonstrated good internal consistency and agreement (Cronbach α=.958; intraclass correlation=0.919; 95% CI 0.842 to 0.959) and was significantly correlated with its paper-based counterpart (Pearson correlation=0.932, P<.001).
Conclusions: This study demonstrated the equivalence of PROs between the app- and paper-based J-OSDI. Implementing the app-based J-OSDI in various scenarios, including telehealth, may have implications for the early diagnosis of DED and longitudinal monitoring of PROs.
Keywords: Ocular Surface Disease Index; dry eye syndrome; equivalence trial; mobile app; mobile health; patient-reported outcome measures; precision medicine; reliability; telemedicine; validity.
©Ken Nagino, Yuichi Okumura, Yasutsugu Akasaki, Kenta Fujio, Tianxiang Huang, Jaemyoung Sung, Akie Midorikawa-Inomata, Keiichi Fujimoto, Atsuko Eguchi, Shokirova Hurramhon, Alan Yee, Maria Miura, Mizu Ohno, Kunihiko Hirosawa, Yuki Morooka, Akira Murakami, Hiroyuki Kobayashi, Takenori Inomata. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 03.08.2023.